印度中部的一家医院启用了AI驱动的IVF,提高了成功率和削减成本。 A hospital in Central India launches AI-powered IVF, boosting success rates and cutting costs.

马哈拉施特拉邦的阿恩什医院使用加尔巴.艾的CDSCO批准的AI平台推出了智能试管婴儿, 成为中印度首家提供这项技术的医院. Aansh Hospital in Chandrapur, Maharashtra, has launched Smart IVF using Garbha.ai’s CDSCO-approved AI platform, becoming the first in Central India to offer the technology. 人工智能系统可改善五个关键的试管婴儿阶段:精子选择,卵子评估,胚胎分类,子宫内膜分析和个性化治疗计划, 植入率可提高25%,成本可降低50%和胚胎生存率可提高94%. The AI system enhances five key IVF stages—sperm selection, egg assessment, embryo grading, endometrial analysis, and personalized treatment planning—boosting implantation rates by up to 25%, reducing costs by up to 50%, and improving embryo viability prediction to 94%. 该系统符合印度的条例,符合标准实验室设备,消除了主观决策,并提供透明、数据驱动的护理。 The system, compliant with Indian regulations and compatible with standard lab equipment, eliminates subjective decision-making and offers transparent, data-driven care. 目前,它是唯一在本区域提供Garbha.ai 5-Production AI套餐的供应商,扩大了在Vidarbha和邻近地区获得先进生育治疗的机会。 It is now the sole provider of the Garbha.ai 5-Product AI Suite in the region, expanding access to advanced fertility treatments in Vidarbha and neighboring areas.